These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21423396)

  • 1. Development of epoxyeicosatrienoic acid analogs with in vivo anti-hypertensive actions.
    Imig JD; Elmarakby A; Nithipatikom K; Wei S; Capdevila JH; Tuniki VR; Sangras B; Anjaiah S; Manthati VL; Sudarshan Reddy D; Falck JR
    Front Physiol; 2010; 1():157. PubMed ID: 21423396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats.
    Baranowska I; Gawrys O; Walkowska A; Olszynski KH; Červenka L; Falck JR; Adebesin AM; Imig JD; Kompanowska-Jezierska E
    Front Pharmacol; 2021; 12():798642. PubMed ID: 35111064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition.
    Hye Khan MA; Pavlov TS; Christain SV; Neckář J; Staruschenko A; Gauthier KM; Capdevila JH; Falck JR; Campbell WB; Imig JD
    Clin Sci (Lond); 2014 Oct; 127(7):463-74. PubMed ID: 24707975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive rats.
    Neckář J; Hye Khan MA; Gross GJ; Cyprová M; Hrdlička J; Kvasilová A; Falck JR; Campbell WB; Sedláková L; Škutová Š; Olejníčková V; Gregorovičová M; Sedmera D; Kolář F; Imig JD
    Clin Sci (Lond); 2019 Apr; 133(8):939-951. PubMed ID: 30979784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.
    Elmarakby AA
    Am J Physiol Regul Integr Comp Physiol; 2012 Feb; 302(3):R321-30. PubMed ID: 22116511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats.
    Walkowska A; Červenka L; Imig JD; Falck JR; Sadowski J; Kompanowska-Jezierska E
    Front Physiol; 2021; 12():622882. PubMed ID: 33584348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury.
    Khan AH; Falck JR; Manthati VL; Campbell WB; Imig JD
    Front Pharmacol; 2014; 5():216. PubMed ID: 25295006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
    Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
    Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with epoxyeicosatrienoic acid analog and 20-hydroxyeicosatetraenoic acid antagonist provides substantial hypotensive effect in spontaneously hypertensive rats.
    Gawrys O; Husková Z; Baranowska I; Walkowska A; Sadowski J; Kikerlová S; Vaňourková Z; Honetschlägerová Z; Škaroupková P; Červenka L; Falck JR; Imig JD; Kompanowska-Jezierska E
    J Hypertens; 2020 Sep; 38(9):1802-1810. PubMed ID: 32384390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels.
    Imig JD; Dimitropoulou C; Reddy DS; White RE; Falck JR
    Microcirculation; 2008 Feb; 15(2):137-50. PubMed ID: 18260004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein phosphatase 2A and Ca2+-activated K+ channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation.
    Dimitropoulou C; West L; Field MB; White RE; Reddy LM; Falck JR; Imig JD
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):50-61. PubMed ID: 17259072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury.
    Imig JD
    Adv Pharmacol; 2022; 94():27-55. PubMed ID: 35659375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney.
    Yu Z; Huse LM; Adler P; Graham L; Ma J; Zeldin DC; Kroetz DL
    Mol Pharmacol; 2000 May; 57(5):1011-20. PubMed ID: 10779386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
    Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally Active Epoxyeicosatrienoic Acid Analogs.
    Campbell WB; Imig JD; Schmitz JM; Falck JR
    J Cardiovasc Pharmacol; 2017 Oct; 70(4):211-224. PubMed ID: 28937442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renal nerves and plasma epoxyeicosatrienoic acids on blood pressure, renal hemodynamics and excretion in spontaneously hypertensive rats.
    Walkowska A; Gawrys O; Cervenka L; Kompanowska-Jezierska E
    J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 36193968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoxyeicosatrienoic acid analogs and vascular function.
    Sudhahar V; Shaw S; Imig JD
    Curr Med Chem; 2010; 17(12):1181-90. PubMed ID: 20158473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5,6-epoxyeicosatrienoic acid mediates the enhanced renal vasodilation to arachidonic acid in the SHR.
    Pomposiello SI; Quilley J; Carroll MA; Falck JR; McGiff JC
    Hypertension; 2003 Oct; 42(4):548-54. PubMed ID: 12939232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive
    Hrdlička J; Neckář J; Papoušek F; Husková Z; Kikerlová S; Vaňourková Z; Vernerová Z; Akat F; Vašinová J; Hammock BD; Hwang SH; Imig JD; Falck JR; Červenka L; Kolář F
    Front Pharmacol; 2019; 10():159. PubMed ID: 30881303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11,12-epoxyeicosatrienoic acid.
    Imig JD; Zhao X; Falck JR; Wei S; Capdevila JH
    J Hypertens; 2001 May; 19(5):983-92. PubMed ID: 11393683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.